The BRAINCURES Discovery Engine (BDE) platform harnesses a unique biological intelligence (BI) approach to de-risk and accelerate preclinical and clinical drug discovery. The BDE is superior to current state-of-the-art methods as it does not require deep learning steps associated with artificial intelligence (AI) as BRAINCURES has mapped out how genes implicated in brain function in healthy animals are organized into a molecular corporation comprised of hierarchically interconnected worker-, manager- and director- target-compound pairs. BRAINCURES now leverage this knowledge to shorten the drug development pathway by at least four years, eliminate preclinical failure and provide an at least 6-fold increase to today’s 1 in 10 clinical success rates. Get in touch to discover how BRAINCURES can help turn questions into translational opportunities for biology-driven precision medicine.